Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

PLK1 Inhibitor PCM-075 Enhances Efficacy of a FLT3 inhibitor in Combination Therapy

americanpharmaceuticalreviewAugust 17, 2017

Tag: PLK1 , Trovagene , AML

PharmaSources Customer Service